Severe allergic reaction (eg, anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, pertussis-, hepatitis B-, or poliovirus-containing vaccine or to any component of PEDIARIX is a contraindication for PEDIARIX
|The GSK Portfolio of DTaP-containing Vaccines:
Identical DTaP Antigen Content for Consistency Across the DTaP Series [1-3]
|Diphtheria toxoid (25 Lf)|
|Tetanus toxoid (10 Lf)|
|Inactivated pertussis toxin (25 mcg)|
|Filamentous hemagglutinin (25 mcg)|
|Pertactin (8 mcg)|
|Type 1 poliovirus (40 DU)|
|Type 2 poliovirus (8 DU)|
|Type 3 poliovirus (32 DU)|
|HBsAg (10 mcg)|
DU=D-antigen units; HBsAg=hepatitis B surface antigen; Lf=limits of flocculation.
Because the pertussis antigens contained in INFANRIX and KINRIX are the same as those in PEDIARIX, children who have received a 3-dose series with PEDIARIX should receive INFANRIX as their fourth dose of DTaP and either INFANRIX or KINRIX as their fifth dose of DTaP, according to the respective Prescribing Information for these vaccines. "scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500"
Sufficient data on the safety and effectiveness of interchanging PEDIARIX, INFANRIX, and KINRIX with DTaP-containing vaccines from different manufacturers are not available. "scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500"[1-2]
|a||Each syringe delivers the labeled dose.|